NewsBenzingaDaré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies Daré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies Benzinga 2026.09.28 12:21 (GMT+0) Open on Benzinga Other news SpaceX Starship Reaches Orbit for First Time Despite Engine Failure SpaceX Dip Buyer Bets Starship Turns Starlink Into a Bigger Cash Cow Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today Barclays Upgrades Liberty Energy to Overweight, Announces $27 Price Target October Brings Volatility, Historically Strong Market Returns: Expert Says Roadmap Favorable IonQ Stock Climbs Monday: What's Happening?
